The  logo

 

Most popular story

Woman exercising (Yuri Arcurs/Dreamstime)

Keeping exercise short and hard: what’s involved and is it worth it?

Giving lifestyle advice often involves encouraging patients to do exercise. Is there a less time-consuming way to exercise but achieve the same health benefits? Rod Tucker investigates

more>

News and views

Syndicate content
  1. Martin Astbury

    Martin Astbury believes changes are needed in how GPs and pharmacists handle prescriptions

    Annotate prescriptions for new medicines, English Pharmacy Board suggests

    23 Apr 14 | 15.41 | England

    Prescriptions for medicines that a patient has not taken previously should be clearly labelled in order to distinguish them from the 80 per cent of prescriptions that are repeats...

    more >

  2. NICE endorses afatinib for NSCLC but says no to pemetrexed

    23 Apr 14 | 15.38 | England Wales

    The National Institute for Health and Care Excellence has today (23 April 2014) issued final and draft guidance...

    more >

  3. Plans for prescribing roles need clarifying, says Scottish Pharmacy Board

    23 Apr 14 | 15.36 | Scotland

    Confusion over exactly which pharmacists will develop prescribing roles needs to be resolved as part of the implementation of “Prescription for excellence” in Scotland..

    more >

  4. European Medicines Agency publishes action plan on medication errors

    23 Apr 14 | 15.31 | EU

    The European Medicines Agency has published an action plan outlining the steps being taken to tackle medication errors in EU member states...

    more >

  5. RPS Faculty update

    23 Apr 14 | 11.40 | England Scotland Wales

    The following individuals represent the most recent cohort of members to be successful in gaining admission to the Royal Pharmaceutical Society Faculty.

    more >

  6. Novartis and GSK merge consumer divisions as part of multi-billion dollar business ventures

    22 Apr 14 | 17.55 | International

    Global pharmaceutical giants — Novartis and GlaxoSmithKline — today (22 April 2014) announced a series of multi-billion dollar "transformative" business ventures . . .  more >

  7. FDA considers technology to screen for cardiotoxicity of new drugs

    22 Apr 14 | 17.50 | International Scotland

    New technology that tests the impact of compounds on cardiac activity and which was developed by scientists at Glasgow University could be adopted by the US Food and Drug Administration . . .

    more >

  8. Combination tablet offers alternative to interferon for hepatitis C genotype 1 infection

    22 Apr 14 | 17.41 | International

    A fixed-dose tablet containing ledipasvir and sofosbuvir is highly effective and well tolerated in a broad range of patients with hepatitis C virus (HCV) genotype 1 infection, show results of two phase III randomised controlled trials. more >

  9. Warning over falsified Herceptin vials

    22 Apr 14 | 17.21 | EU

    Stolen, falsified vials of Herceptin (trastuzumab) are in circulation in the European Union and must not be used...

    more >

  10. Patients with advanced liver disease and hepatitis C infection see benefit with multi-drug regimen

    22 Apr 14 | 17.06 | International

    An oral multi-drug regimen has shown marked efficacy in patients with cirrhotic liver disease and hepatitis C virus (HCV) genotype 1 infection . . . more >


 Talking point

The Pharmaceutical Journal re-launch: Content structure

As discussed in a previous post, The Pharmaceutical Journal aims to become your first and main choice on all platforms including print, online and mobile devices...

more>

Jigsaw (dtje/dreamstime.com)
Syndicate content